← brief for 2026-10-14 · Slowing decline

Short-term superiority in proteinuria control with exploratory longitudinal trajectories: finerenone-dapagliflozin combination in non-diabetic kidney disease

Article C Peer reviewed Observational

Key takeaways

This study looked at 327 people with kidney disease who do not have diabetes. It found that taking two drugs together helped lower protein in the urine more than taking just one. This shows a link between the drug combo and better control, but it is not proof of cause.

Who did this work

Mali Zhu (Nanjing Drum Tower Hospital) · Yingyi Deng (China Pharmaceutical University) · Lijun Su (Nanjing Drum Tower Hospital) · Haixia Zhang (Nanjing Drum Tower Hospital) · Yun Yang (Nanjing Drum Tower Hospital) · Lulu Wang (Changsha Medical University)

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-10-13
https://doi.org/10.3389/fphar.2026.1918911